Skip to search formSkip to main contentSkip to account menu

regorafenib 40 MG Oral Tablet [Stivarga]

Known as: REGORAFENIB MONOHYDRATE 40 mg ORAL TABLET, FILM COATED [Stivarga], Stivarga 40 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

16 relations
Croscarmellose SodiumMagnesium stearateOral TabletPOLYETHYLENE GLYCOL 3350

Broader (1)

regorafenib Oral Tablet [Stivarga]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract 1192: Regorafenib (Stivarga®) reverses BCRP-mediated multidrug resistancein vitroandin vivo
2016
2016
轉移性大腸直腸癌新藥－－Regorafenib （Stivarga（R）癌瑞格）
2013
2013
Stivarga® (regorafenib) rekommenderas för godkännande i EU för behandling av spridd tarmcancer.
CHMP-kommitte rekommenderar godkannande av marknadsforingstillstand for Stivarga® (regorafenib) tabletter for behandling av… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)